Oncolmmune, Inc.
2Patents
2Active
2Granted
40Portfolio score
Filing activity: Oct 21, 2014 → Aug 11, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9611309B2 | Methods of use of soluble CD24 for therapy of rheumatoid arthritis | Chemistry; Metallurgy | 0 | Active |
| US9623070B2 | Uses of hypoxia-inducible factor inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.